Jurox- Zoletil
true
true
{{custommediabasic::headline_less_padding_bottom}}
#0557A2
#D23B97
{{custommediabasic::custom_background}}
30px 0 30px 0
{{custommediabasic::logo_url}}
{{custommediabasic::logo}}
{{custommediabasic::logo_alt_text}}
200
{{custommediabasic::logo_at_bottom}}
{{custommediabasic::header_image_url}}
/uploads/us_zoletil_5_m_l_blue_top_2020-7d73ea9dda9d3d6a46e9d4a45c5525c0.png
{{custommediabasic::header_image_alt_text}}
Convenient & Versatile Anesthesia
{{custommediabasic::headline_smaller}}
2 Molecules, 1 Injection
{{custommediabasic::subhead_url}}
true
{{custommediabasic::headline_subhead_below_header_image}}
Zoletil™ (tiletamine and zolazepam) for Injection combines 2 complementary molecules in an optimized formulation for anesthesia in both dogs and cats. The combination of Tiletamine and Zolazepam provides rapid onset anesthesia and analgesia. Zoletil™ for Injection in your clinic can provide:
- Versatility: Dose-dependent duration and depth of dissociative anesthesia
- Convenience: Ready-to-use combination containing two molecules in a fixed ratio formulation
- Short Duration Procedures: Suitable for common procedures requiring anesthesia and analgesia
#888888
true
true
true
{{custommediabasic::cta_callout_secondary}}
{{custommediabasic::cta_url}}
Purchase 9 vials and receive 3 free
Learn More & Get Yours
{{custommediabasic::footnote_center}}
Important Safety Information
As with all drugs, side effects may occur. Zoletil™ for Injection should not be used in dogs and cats with pancreatic disease, renal pathology or impairment of renal function, or severe cardiac or pulmonary dysfunction. Do not use at any stage of pregnancy or for Caesarean section since a study has shown that tiletamine and zolazepam injection crosses the placental barrier. Do not use phenothiazine-derivative drugs concomitantly with Zoletil™ for Injection as the combination produces respiratory and myocardial depression, hypotension, and hypothermia. Pulmonary edema has been reported in cats. Respiratory depression may occur following administration of high doses of Zoletil™. Copious salivation may occur during Zoletil™ anesthesia and may be controlled by giving atropine sulfate, USP as a concurrent medication. Vomiting upon emergence, involuntary muscle twitching and cardiac arrest have occasionally been reported with Zoletil™. For complete prescribing information visit https://www.jurox.com/us/product/zoletil-injection.
{{custommediabasic::footnote_larger}}
{{custommediabasic::pre_footer_center}}
{{custommediabasic::pre_footer_larger}}
{{custommediabasic::pre_footer_copy}}
{{custommediabasic::preview_text}}
|
Convenient & Versatile Anesthesia
|
|
2 Molecules, 1 Injection
|
|
|
Zoletil™ (tiletamine and zolazepam) for Injection combines 2 complementary molecules in an optimized formulation for anesthesia in both dogs and cats. The combination of Tiletamine and Zolazepam provides rapid onset anesthesia and analgesia. Zoletil™ for Injection in your clinic can provide: - Versatility: Dose-dependent duration and depth of dissociative anesthesia
- Convenience: Ready-to-use combination containing two molecules in a fixed ratio formulation
- Short Duration Procedures: Suitable for common procedures requiring anesthesia and analgesia
|
|
Purchase 9 vials and receive 3 free
|
|
Purchase 9 vials and receive 3 free
|
|
|
|
Important Safety Information
As with all drugs, side effects may occur. Zoletil™ for Injection should not be used in dogs and cats with pancreatic disease, renal pathology or impairment of renal function, or severe cardiac or pulmonary dysfunction. Do not use at any stage of pregnancy or for Caesarean section since a study has shown that tiletamine and zolazepam injection crosses the placental barrier. Do not use phenothiazine-derivative drugs concomitantly with Zoletil™ for Injection as the combination produces respiratory and myocardial depression, hypotension, and hypothermia. Pulmonary edema has been reported in cats. Respiratory depression may occur following administration of high doses of Zoletil™. Copious salivation may occur during Zoletil™ anesthesia and may be controlled by giving atropine sulfate, USP as a concurrent medication. Vomiting upon emergence, involuntary muscle twitching and cardiac arrest have occasionally been reported with Zoletil™. For complete prescribing information visit https://www.jurox.com/us/product/zoletil-injection.
|
|
|
|
</head>
<body style="-ms-text-size-adjust:100%;-webkit-text-size-adjust:100%;margin:0;min-width:100%;padding:0;width:100%" data-bg-color="#e8e8e8" bgcolor="#e8e8e8">
{{custommediabasic::preview_text}}
|
Convenient & Versatile Anesthesia
|
|
2 Molecules, 1 Injection
|
|
|
|
Zoletil™ (tiletamine and zolazepam) for Injection combines 2 complementary molecules in an optimized formulation for anesthesia in both dogs and cats. The combination of Tiletamine and Zolazepam provides rapid onset anesthesia and analgesia. Zoletil™ for Injection in your clinic can provide: - Versatility: Dose-dependent duration and depth of dissociative anesthesia
- Convenience: Ready-to-use combination containing two molecules in a fixed ratio formulation
- Short Duration Procedures: Suitable for common procedures requiring anesthesia and analgesia
|
|
Purchase 9 vials and receive 3 free
|
|
Purchase 9 vials and receive 3 free
|
|
|
|
Important Safety Information
As with all drugs, side effects may occur. Zoletil™ for Injection should not be used in dogs and cats with pancreatic disease, renal pathology or impairment of renal function, or severe cardiac or pulmonary dysfunction. Do not use at any stage of pregnancy or for Caesarean section since a study has shown that tiletamine and zolazepam injection crosses the placental barrier. Do not use phenothiazine-derivative drugs concomitantly with Zoletil™ for Injection as the combination produces respiratory and myocardial depression, hypotension, and hypothermia. Pulmonary edema has been reported in cats. Respiratory depression may occur following administration of high doses of Zoletil™. Copious salivation may occur during Zoletil™ anesthesia and may be controlled by giving atropine sulfate, USP as a concurrent medication. Vomiting upon emergence, involuntary muscle twitching and cardiac arrest have occasionally been reported with Zoletil™. For complete prescribing information visit https://www.jurox.com/us/product/zoletil-injection.
|
|
|
|
